Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.
about
Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methodsOncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsDevelopment of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adaptersOptimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systemsPhage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation.Molecular engineering of viral gene delivery vehiclesA strategy for adenovirus vector targeting with a secreted single chain antibody.Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerCurrent issues and future directions of oncolytic adenoviruses.Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targetingTargeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein.Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.Adenovirus receptors and their implications in gene deliveryLigand-directed targeting of genes to the site of disease.Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridgeArtificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines.Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands.Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors.Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.Chapter two--Adenovirus strategies for tissue-specific targeting.Retargeting adenoviral vectors to improve gene transfer into tumorsEpidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.Transductional targeting of adenovirus vectors for gene therapyConditionally replicative adenovirus for gastrointestinal cancers.Oncolytic viral therapies.Gene therapy trials for the treatment of high-grade gliomas.Oncolytic viruses for cancer therapy I. Cell-external factors: virus entry and receptor interaction.Oncolytic adenoviruses - selective retargeting to tumor cells.Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.Evolving gene therapy approaches for osteosarcoma using viral vectors: reviewCancer, stem cells, and oncolytic viruses.Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.Adenoviral vector-based strategies for cancer therapy.CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter.Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptorUsing viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43.Retargeting of viruses to generate oncolytic agents.Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.
P2860
Q24683349-51961A9C-BBCA-49BD-8CC3-29CAA6B23021Q26776553-A8C7D0E3-1D35-4DBD-9060-E5D66AF3DE5CQ27676519-E4E2202D-610B-4C75-BEB1-3E881E766F18Q28476268-ECBA3C4F-9F4C-4A5D-AB6D-611F0A86CF94Q30685512-42496652-71E5-42BA-BCDB-C62FB02F08C1Q33353795-50EC2882-8375-4994-BA61-6E5DFAE251F7Q33520212-A31B09BF-C9FA-475B-BFAB-7D71F53809E6Q33584756-48E9A048-97B3-4C94-A94C-C0001FBC0F46Q33730705-A0ED0DF0-EFD7-43A9-9FE9-4741681AEFF0Q33740415-4CC3B673-0A5D-4DF6-B35C-E8D792C50AE9Q33837118-28065FE2-F064-4E79-A7E6-1DDA9002590FQ33866165-2A470514-7C28-45CB-899C-3B1AECDADB96Q33994011-9FEB3607-E492-4FF2-A80A-ACAA29023BB5Q34168868-DACAC817-CD05-4D10-8DAC-2141146611F8Q34226547-C6032B37-CA5E-40DE-9FB1-3AD93578F4C4Q34330435-4E6EC7AA-3E57-4EB5-8287-BE3A9569A130Q34354192-7C0A4787-A8C4-4FF4-B9AC-8B7124E4F89FQ34534285-3F1F8952-FB4D-45F1-A663-233A109AB630Q34621654-04D44C9C-8898-4276-910C-CDD53B7AD0C0Q34643252-0200E6FF-3F21-442E-A510-443644B41164Q34699410-639E1FF6-07DF-44A9-9090-2C771012C740Q34757186-0D61DE71-15F0-4C74-B994-A36B8074575FQ35609035-EC56A440-FC49-4325-A524-C549226DCACDQ35842604-42FEF02E-F2B5-4C56-9285-1399F9B8F219Q35852258-A69910FC-1F5F-4D77-B76D-0398AC49E6D5Q35880459-C4183548-5960-4FE7-9581-8C9D9659BC89Q36072752-3F4E7842-2D52-4DAA-8D55-78A72BDECAAEQ36318189-14E60AFE-0842-4188-9778-8EA2679F0F3BQ36387898-259AFBE7-F700-4DD0-BFEC-F63E8FC04421Q36692759-39DD054B-2727-48C6-A94A-241C245A38D5Q37209758-397B5319-F46A-4854-9D9A-7B21518DC28CQ37227135-5F8CF3E1-3D7B-40FC-84CA-4E25E6A51731Q37409025-BD337919-BF6C-4045-A4FE-089D3C569F9AQ37420781-C068457E-A9FE-43C1-B2E2-E4E3E7E7954EQ37513318-E85239B3-ABD8-4F3F-AEBC-6DE98F09E970Q37615161-2DDDB6A3-48C6-4B33-90E2-D2FE108F1818Q37619767-1368CC8F-E047-4837-BCFB-A5A2EE498BF4Q37982062-0BC4781D-BAA8-4703-B697-5042B78E5E15Q38333842-84F1541F-75BE-4FD6-B847-5350CCC60FC2Q38614156-01EE1384-1D12-4DD6-939C-99BCB89F2415
P2860
Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ectodomain of coxsackievirus a ...... actor receptor-positive cells.
@ast
Ectodomain of coxsackievirus a ...... actor receptor-positive cells.
@en
type
label
Ectodomain of coxsackievirus a ...... actor receptor-positive cells.
@ast
Ectodomain of coxsackievirus a ...... actor receptor-positive cells.
@en
prefLabel
Ectodomain of coxsackievirus a ...... actor receptor-positive cells.
@ast
Ectodomain of coxsackievirus a ...... actor receptor-positive cells.
@en
P2093
P2860
P1433
P1476
Ectodomain of coxsackievirus a ...... actor receptor-positive cells.
@en
P2093
B E Rogers
E Kashentseva
I Dmitriev
V Krasnykh
P2860
P304
P356
10.1128/JVI.74.15.6875-6884.2000
P577
2000-08-01T00:00:00Z